These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 32007619)
41. Evaluation of the antibacterial and inhibitory activity of NorA and MepA efflux pumps from Staphylococcus aureus by diosgenin. do Socorro Costa M; da Silva ARP; Araújo NJS; Filho JMB; Tavares JF; de Freitas TS; Pereira Junior FN; de Sousa EO; Maia FPA; de Vasconcelos JEL; Pinheiro JCA; Coutinho HDM Life Sci; 2022 Nov; 308():120978. PubMed ID: 36122765 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of the antibacterial activity of hecogenin acetate and its inhibitory potential of NorA and MepA efflux pumps from Staphylococcus aureus. Santos Araújo NJ; Pereira da Silva AR; Costa MDS; Pereira Silva CA; Sampaio de Freitas T; Oliveira de Sousa E; Barbosa Filho JM; Lobo Soares de Matos YM; Melo Coutinho HD; Andrade-Pinheiro JC Microb Pathog; 2023 Jan; 174():105925. PubMed ID: 36462578 [TBL] [Abstract][Full Text] [Related]
43. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors. Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763 [TBL] [Abstract][Full Text] [Related]
44. Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus. Wani NA; Singh S; Farooq S; Shankar S; Koul S; Khan IA; Rai R Bioorg Med Chem Lett; 2016 Sep; 26(17):4174-8. PubMed ID: 27503686 [TBL] [Abstract][Full Text] [Related]
45. Modulation of drug resistance in Staphylococcus aureus by a kaempferol glycoside from Herissantia tiubae (Malvaceae). Falcão-Silva VS; Silva DA; Souza Mde F; Siqueira-Junior JP Phytother Res; 2009 Oct; 23(10):1367-70. PubMed ID: 19224523 [TBL] [Abstract][Full Text] [Related]
46. A novel bi-functional chalcone inhibits multi-drug resistant Staphylococcus aureus and potentiates the activity of fluoroquinolones. Gupta VK; Gaur R; Sharma A; Akther J; Saini M; Bhakuni RS; Pathania R Bioorg Chem; 2019 Mar; 83():214-225. PubMed ID: 30380450 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of the NorA efflux pump of S. aureus by (Z)-5-(4-Fluorobenzylidene)-Imidazolidines. Faillace MS; Alves Borges Leal AL; Araújo de Oliveira Alcântara F; Ferreira JHL; de Siqueira-Júnior JP; Sampaio Nogueira CE; Barreto HM; Peláez WJ Bioorg Med Chem Lett; 2021 Jan; 31():127670. PubMed ID: 33161124 [TBL] [Abstract][Full Text] [Related]
48. Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA. López Y; Tato M; Gargallo-Viola D; Cantón R; Vila J; Zsolt I Int J Antimicrob Agents; 2020 Sep; 56(3):106082. PubMed ID: 32659467 [TBL] [Abstract][Full Text] [Related]
49. Comparative Antibacterial and Efflux Pump Inhibitory Activity of Isolated Nerolidol, Farnesol, and α-Bisabolol Sesquiterpenes and Their Liposomal Nanoformulations. Santana JEG; Oliveira-Tintino CDM; Gonçalves Alencar G; Siqueira GM; Sampaio Alves D; Moura TF; Tintino SR; de Menezes IRA; Rodrigues JPV; Gonçalves VBP; Nicolete R; Emran TB; Gonçalves Lima CM; Ahmad SF; Coutinho HDM; da Silva TG Molecules; 2023 Nov; 28(22):. PubMed ID: 38005371 [TBL] [Abstract][Full Text] [Related]
50. The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Smith EC; Kaatz GW; Seo SM; Wareham N; Williamson EM; Gibbons S Antimicrob Agents Chemother; 2007 Dec; 51(12):4480-3. PubMed ID: 17664318 [TBL] [Abstract][Full Text] [Related]
51. Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains. Dos Santos Barbosa CR; Scherf JR; de Freitas TS; de Menezes IRA; Pereira RLS; Dos Santos JFS; de Jesus SSP; Lopes TP; de Sousa Silveira Z; de Morais Oliveira-Tintino CD; Júnior JPS; Coutinho HDM; Tintino SR; da Cunha FAB J Bioenerg Biomembr; 2021 Aug; 53(4):489-498. PubMed ID: 34159523 [TBL] [Abstract][Full Text] [Related]
52. Chemical composition and potentiating action of Norfloxacin mediated by the essential oil of Piper caldense C.D.C. against Staphylococcus aureus strains overexpressing efflux pump genes. Leal ALAB; Bezerra CF; Confortin C; da Silva LE; Marinho EM; Marinho MM; Vasconcelos MA; da Silva TG; Marinho ES; Teixeira AMR; Coutinho HDM; Barreto HM; Dos Santos HS Arch Microbiol; 2021 Sep; 203(7):4727-4736. PubMed ID: 34052872 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of the multidrug efflux pump LmrS from Staphylococcus aureus by cumin spice Cuminum cyminum. Kakarla P; Floyd J; Mukherjee M; Devireddy AR; Inupakutika MA; Ranweera I; Kc R; 'Shrestha U; Cheeti UR; Willmon TM; Adams J; Bruns M; Gunda SK; Varela MF Arch Microbiol; 2017 Apr; 199(3):465-474. PubMed ID: 27830269 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics. Schindler BD; Jacinto P; Kaatz GW Future Microbiol; 2013 Apr; 8(4):491-507. PubMed ID: 23534361 [TBL] [Abstract][Full Text] [Related]
55. Systematic Analysis of Efflux Pump-Mediated Antiseptic Resistance in Staphylococcus aureus Suggests a Need for Greater Antiseptic Stewardship. LaBreck PT; Bochi-Layec AC; Stanbro J; Dabbah-Krancher G; Simons MP; Merrell DS mSphere; 2020 Jan; 5(1):. PubMed ID: 31941819 [No Abstract] [Full Text] [Related]
56. Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position. Felicetti T; Cannalire R; Nizi MG; Tabarrini O; Massari S; Barreca ML; Manfroni G; Schindler BD; Cecchetti V; Kaatz GW; Sabatini S Eur J Med Chem; 2018 Jul; 155():428-433. PubMed ID: 29908437 [TBL] [Abstract][Full Text] [Related]
57. Antibacterial and antibiotic modifying activity, ADMET study and molecular docking of synthetic chalcone (E)-1-(2-hydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying NorA and MepA efflux pumps. Rocha JE; de Freitas TS; da Cunha Xavier J; Pereira RLS; Junior FNP; Nogueira CES; Marinho MM; Bandeira PN; de Oliveira MR; Marinho ES; Teixeira AMR; Dos Santos HS; Coutinho HDM Biomed Pharmacother; 2021 Aug; 140():111768. PubMed ID: 34058442 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of ellagic acid and gallic acid as efflux pump inhibitors in strains of Staphylococcus aureus. Macêdo NS; Barbosa CRDS; Bezerra AH; Silveira ZS; da Silva L; Coutinho HDM; Dashti S; Kim B; da Cunha FAB; da Silva MV Biol Open; 2022 Oct; 11(10):. PubMed ID: 36063129 [TBL] [Abstract][Full Text] [Related]
59. Modulation of the norfloxacin resistance in Staphylococcus aureus by Cordia verbenaceae DC. Matias EF; Santos KK; Falcão-Silva VS; Siqueira-Junior JP; Costa JG; Coutinho HD Indian J Med Res; 2013 Jan; 137(1):178-82. PubMed ID: 23481069 [TBL] [Abstract][Full Text] [Related]
60. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees. Holler JG; Christensen SB; Slotved HC; Rasmussen HB; Gúzman A; Olsen CE; Petersen B; Mølgaard P J Antimicrob Chemother; 2012 May; 67(5):1138-44. PubMed ID: 22311936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]